98% MGCD0103 MG0103 Mocetinosta CAS 726169-73-9
COA TDS 10 Inquiries
726169-73-9
Pharmaceutical Grade
99%
shenzhen
HS
25kg drum
Yes
2026-11-08
Ivermectin,Active pharmaceutical ingredients,Cosmetics material,Chemical intermediate,Nootropic,Food additive
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceMocetinostat (MGCD0103) is a potent, orally active and isotype-selective HDAC (Class I/IV) inhibitor with IC50s of 0.15, 0.29, 1.66 and 0.59 μM for HDAC1, HDAC2, HDAC3 and HDAC11, respectively. Mocetinostat shows no inhibition on HDAC4, HDAC5, HDAC6, HDAC7, or HDAC8.
N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide is a member of benzamides.|Mocetinostat has been used in trials studying the treatment of Lymphoma, Urothelial Carcinoma, Relapsed and Refractory, Myelodysplastic Syndrome, and Metastatic Leiomyosarcoma, among others.|Mocetinostat is a rationally designed, orally available, Class 1-selective, small molecule, 2-aminobenzamide HDAC inhibitor with potential antineoplastic activity. Mocetinostat binds to and inhibits Class 1 isoforms of HDAC, specifically HDAC 1, 2 and 3, which may result in epigenetic changes in tumor cells and so tumor cell death; although the exact mechanism has yet to be defined, tumor cell death may occur through the induction of apoptosis, differentiation, cell cycle arrest, inhibition of DNA repair, upregulation of tumor suppressors, down regulation of growth factors, oxidative stress, and autophagy, among others. Overexpression of Class I HDACs 1, 2 and 3 has been found in many tumors and has been correlated with a poor prognosis.CertificatesBasic Info-
Product Name:
Mocetinostat
Other Name:Benzamide,N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]-;N-(2-Aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide;MGCD 0103;Mocetinostat;MG 0103
CAS No.:726169-73-9
Molecular Formula:C23H20N6O
InChIKeys:InChIKey=HRNLUBSXIHFDHP-UHFFFAOYSA-N
Molecular Weight:396.452
Exact Mass:396.44
EC Number:232-668-6
UNII:A6GWB8T96J
DSSTox ID:DTXSID80222945
NCI Thesaurus Code:C62521
HScode:2933990090
Categories:
Characteristics-
PSA:
106
XLogP3:2.8
Density:1.3±0.1 g/cm3
Refractive Index:1.730
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Ivermectin,Active pharmaceutical ingredients,Cosmetics material,Chemical intermediate,Nootropic,Food additive
-
Location:
6 floor Baoyilongji Building B Weiyang Area, Fengcheng 8 Road, Xi'an city, Shaanxi, 710000, China
-
Payment Terms:
L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2017
Company Certificates-
ISO
-
ISO
-
-
Inquiry History10 Inquiries
Country Product Purchase Quantity Date Posted
United States
Mocetinostat
1 G Sep 2, 2026
United States
mocetinostat
2 G Oct 19, 2026
Poland
Mocetinostat
1 G Sep 11, 2026
United States
Mocetinostat
4 G Aug 3, 2026
Thailand
Mocetinostat
2 G Jul 4, 2026
United States
Mocetinostat
2 G Mar 28, 2026
United Kingdom
Mocetinostat
1 G Oct 5, 2026
Netherlands
Mocetinostat
1 G Sep 21, 2026
Romania
Mocetinostat
2 G Sep 19, 2026
United States
Mocetinostat
2 G May 18, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Gibberellic Acid raw material powder CAS 77-06-5 Gibberellic Acid
Pharmaceutical Grade / 99%
-
-
-
-
Glycolic acid raw powder CAS 79-14-1 Glycolic acid
Pharmaceutical Grade / 99%
-
-
-
-
China Manufacturer Supply High Purity CAS 151-21-3 Sodium Dodecyl Sulfate Powder
Pharmaceutical Grade / 99%
-
-
-
-
Oxytetracycline HNB Supply best price of Oxytetracycline 99% Powder CAS 79-57-2
Pharmaceutical Grade / 99%
-
-
-
-
Chondroitin Sulfate Food Grade CAS 9007-28-7 Chondroitin Sulfate 99% Powder
Pharmaceutical Grade / 99%
-
-
-
-
6-Diazo-5-oxo-L-norleucine raw material powder Cas 157-03-9
Pharmaceutical Grade / 99%
-


